BioAge Labs, a clinical-stage biotech company developing therapies for metabolic diseases, has attracted attention from Wall ...

Azelaprag, an oral small molecule agonist of the apelin receptor, is currently in a Phase 2 clinical trial named STRIDES, which is investigating its efficacy in combination with tirzepatide for ...

Nearly 250,000 people in England could access a weight loss injection on the NHS. Tirzepatide is prescribed for type 2 diabetes, but has been shown in clinical trials to be effective for weight loss.

The Inter-Agency Council Against Trafficking (IACAT), the Office of the Prosecutor General (OPG), and the Office of the Solicitor General (OSG) have signed a memorandum of agreement (MOA) for a legal ...

On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved ...

The drug uses the active ingredient tirzepatide and was approved by the FDA in May 2022 for type 2 diabetes; although McCaskill said her blood sugar was elevated, she didn’t have diabetes ...

In a reversal, the Food and Drug Administration (FDA) said it will allow some compounding pharmacies to temporarily make their own versions of tirzepatide, the active ingredient in Eli Lilly’s ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

The U.S. Food and Drug Administration (FDA) is considering removing the tirzepatide medications Mounjaro (for diabetes) and Zepbound (for obesity) from its drug shortage list. If that happens ...

The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness, as well as changing how the body processess food. (In other countries, tirzepatide is also ...